REPORT ID 3359

United States Hypoxia Inducible Factor 1 Alpha Inhibitor Market Report 2019

Publish Date
2019
Pages
109
Format
Electronic (PDF)

In this report, the United States Hypoxia Inducible Factor 1 Alpha Inhibitor market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Hypoxia Inducible Factor 1 Alpha Inhibitor in these regions, from   2019 to 2025 (forecast).

United States Hypoxia Inducible Factor 1 Alpha Inhibitor market competition by top manufacturers/players, with Hypoxia Inducible Factor 1 Alpha Inhibitor sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Aileron Therapeutics, Inc.
    CASI Pharmaceuticals Inc.
    Cerulean Pharma, Inc.
    F. Hoffmann-La Roche Ltd.
    InterMed Discovery GmbH
    OncoImmune, Inc.
    Peloton Therapeutics, Inc.
    RXi Pharmaceuticals Corporation
    Sorrento Therapeutics, Inc.
    Transcriptogen Ltd
    Vascular Biogenics Ltd.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    BC-001
    CASI-2ME2
    CRLX-101
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Solid Tumor
    Acute Myelocytic Leukemia
    Colorectal Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Hypoxia Inducible Factor 1 Alpha Inhibitor Market  Report 2019
1 Hypoxia Inducible Factor 1 Alpha Inhibitor Overview
    1.1 Product Overview and Scope of Hypoxia Inducible Factor 1 Alpha Inhibitor
    1.2 Classification of Hypoxia Inducible Factor 1 Alpha Inhibitor by Product Category
        1.2.1 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Sales Volume) Comparison by Type ( 2014-2024)
        1.2.2 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Sales Volume) Market Share by Type (Product Category)  in 2018
        1.2.3 BC-001
        1.2.4 CASI-2ME2
        1.2.5 CRLX-101
        1.2.6 Others
    1.3 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Market by Application/End Users
        1.3.1 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Consumption) and Market Share Comparison by Application ( 2014-2024)
        1.3.2 Solid Tumor
        1.3.3 Acute Myelocytic Leukemia
        1.3.4 Colorectal Cancer
        1.3.5 Others
    1.4 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Market by Region
        1.4.1 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 The West Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect ( 2014-2024)
        1.4.3 Southwest Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect ( 2014-2024)
        1.4.4 The Middle Atlantic Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect ( 2014-2024)
        1.4.5 New England Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect ( 2014-2024)
        1.4.6 The South Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect ( 2014-2024)
        1.4.7 The Midwest Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect ( 2014-2024)
    1.5 United States Market Size (Value and Volume) of Hypoxia Inducible Factor 1 Alpha Inhibitor ( 2014-2024)
        1.5.1 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Growth Rate ( 2014-2024)
        1.5.2 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate ( 2014-2024)

2 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Market Competition by Players/Suppliers
    2.1 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Market Share of Key Players/Suppliers ( 2014-2019)
    2.2 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Share by Players/Suppliers ( 2014-2019)
    2.3 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Average Price by Players/Suppliers ( 2014-2019)
    2.4 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Market Competitive Situation and Trends
        2.4.1 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Market Concentration Rate
        2.4.2 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturing Base Distribution, Sales Area, Product Type

3 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (Volume) and Revenue (Value) by Region ( 2014-2019)
    3.1 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Market Share by Region ( 2014-2019)
    3.2 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Market Share by Region ( 2014-2019)
    3.3 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Price by Region ( 2014-2019)

4 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (Volume) and Revenue (Value) by Type (Product Category) ( 2014-2019)
    4.1 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Market Share by Type (Product Category) ( 2014-2019)
    4.2 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Market Share by Type ( 2014-2019)
    4.3 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Price by Type ( 2014-2019)
    4.4 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate by Type ( 2014-2019)

5 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (Volume) by Application ( 2014-2019)
    5.1 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Market Share by Application ( 2014-2019)
    5.2 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate by Application ( 2014-2019)
    5.3 Market Drivers and Opportunities

6  United States Hypoxia Inducible Factor 1 Alpha Inhibitor Players/Suppliers Profiles and Sales Data
    6.1 Aileron Therapeutics, Inc.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 CASI Pharmaceuticals Inc.
        6.2.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 Cerulean Pharma, Inc.
        6.3.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 F. Hoffmann-La Roche Ltd.
        6.4.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 InterMed Discovery GmbH
        6.5.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 OncoImmune, Inc.
        6.6.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Peloton Therapeutics, Inc.
        6.7.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 RXi Pharmaceuticals Corporation
        6.8.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview
    6.9 Sorrento Therapeutics, Inc.
        6.9.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.9.4 Main Business/Business Overview
    6.10 Transcriptogen Ltd
        6.10.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.10.4 Main Business/Business Overview
    6.11 Vascular Biogenics Ltd.

7 Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturing Cost Analysis
    7.1 Hypoxia Inducible Factor 1 Alpha Inhibitor Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Hypoxia Inducible Factor 1 Alpha Inhibitor Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Hypoxia Inducible Factor 1 Alpha Inhibitor Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Value and Volume) Forecast ( 2019-2025)
    11.1 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume, Revenue Forecast ( 2019-2025)
    11.2 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume Forecast by Type ( 2019-2025)
    11.3 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume Forecast by Application ( 2019-2025)
    11.4 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume Forecast by Region ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer